Erzsébet Horváth-Puhó, Lars Pedersen, Søren Korsgaard Martiny, Lau Amdisen, Jakob Hansen Viuff, Ola Ekholm, Henrik Toft Sørensen
{"title":"队列概况:丹麦静脉血栓栓塞队列-丹麦国家健康调查和健康登记之间的联系。","authors":"Erzsébet Horváth-Puhó, Lars Pedersen, Søren Korsgaard Martiny, Lau Amdisen, Jakob Hansen Viuff, Ola Ekholm, Henrik Toft Sørensen","doi":"10.2147/CLEP.S522468","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Venous thromboembolism (VTE) is a common disease with a serious prognosis. Nonetheless, many aspects of this multicausal disease are poorly understood. The aim of establishing <i>The Danish Venous Thromboembolism Cohort</i> was to study VTE risk and prognosis within a life-course context.</p><p><strong>Methods: </strong><i>The Danish Venous Thromboembolism Cohort</i> was based on respondents to the questionnaire-based Danish National Health Survey (DNHS) conducted in 2010, 2013, and 2017 and was linked to Danish national health and administrative registries.</p><p><strong>Results: </strong>A total of 474,022 unique respondents to the DNHS were included in this cohort, 8,460 of whom were diagnosed with VTE before the survey response date. The survey's response rate varied between 54% and 60%. The median age at the survey response date was 54 years (interquartile range: 40-66 years), and 46.1% of respondents were men. The cohort contains detailed information on lifestyle factors (smoking habits, alcohol consumption, physical activity level, and dietary habits), health status indicators (healthcare-seeking behavior, body mass index, self-rated health, and mental distress), and self-reported morbidities. In addition, the survey data were linked to records in Danish medical and administrative registries to obtain information on clinical data and outcomes, including hospitalizations, medication use, laboratory test results, labor market participation, vital status, and causes of death.</p><p><strong>Discussion: </strong><i>The Danish Venous Thromboembolism Cohort</i> is a valuable data resource for use in future studies on VTE research, with a focus on risk factors, complications, interactions, and prognosis.</p>","PeriodicalId":10362,"journal":{"name":"Clinical Epidemiology","volume":"17 ","pages":"485-495"},"PeriodicalIF":3.2000,"publicationDate":"2025-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12129029/pdf/","citationCount":"0","resultStr":"{\"title\":\"Cohort Profile: <i>The Danish Venous Thromboembolism Cohort</i> - A Linkage Between Danish National Health Surveys and Health Registers.\",\"authors\":\"Erzsébet Horváth-Puhó, Lars Pedersen, Søren Korsgaard Martiny, Lau Amdisen, Jakob Hansen Viuff, Ola Ekholm, Henrik Toft Sørensen\",\"doi\":\"10.2147/CLEP.S522468\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Venous thromboembolism (VTE) is a common disease with a serious prognosis. Nonetheless, many aspects of this multicausal disease are poorly understood. The aim of establishing <i>The Danish Venous Thromboembolism Cohort</i> was to study VTE risk and prognosis within a life-course context.</p><p><strong>Methods: </strong><i>The Danish Venous Thromboembolism Cohort</i> was based on respondents to the questionnaire-based Danish National Health Survey (DNHS) conducted in 2010, 2013, and 2017 and was linked to Danish national health and administrative registries.</p><p><strong>Results: </strong>A total of 474,022 unique respondents to the DNHS were included in this cohort, 8,460 of whom were diagnosed with VTE before the survey response date. The survey's response rate varied between 54% and 60%. The median age at the survey response date was 54 years (interquartile range: 40-66 years), and 46.1% of respondents were men. The cohort contains detailed information on lifestyle factors (smoking habits, alcohol consumption, physical activity level, and dietary habits), health status indicators (healthcare-seeking behavior, body mass index, self-rated health, and mental distress), and self-reported morbidities. In addition, the survey data were linked to records in Danish medical and administrative registries to obtain information on clinical data and outcomes, including hospitalizations, medication use, laboratory test results, labor market participation, vital status, and causes of death.</p><p><strong>Discussion: </strong><i>The Danish Venous Thromboembolism Cohort</i> is a valuable data resource for use in future studies on VTE research, with a focus on risk factors, complications, interactions, and prognosis.</p>\",\"PeriodicalId\":10362,\"journal\":{\"name\":\"Clinical Epidemiology\",\"volume\":\"17 \",\"pages\":\"485-495\"},\"PeriodicalIF\":3.2000,\"publicationDate\":\"2025-05-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12129029/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Epidemiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2147/CLEP.S522468\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Epidemiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/CLEP.S522468","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
Cohort Profile: The Danish Venous Thromboembolism Cohort - A Linkage Between Danish National Health Surveys and Health Registers.
Introduction: Venous thromboembolism (VTE) is a common disease with a serious prognosis. Nonetheless, many aspects of this multicausal disease are poorly understood. The aim of establishing The Danish Venous Thromboembolism Cohort was to study VTE risk and prognosis within a life-course context.
Methods: The Danish Venous Thromboembolism Cohort was based on respondents to the questionnaire-based Danish National Health Survey (DNHS) conducted in 2010, 2013, and 2017 and was linked to Danish national health and administrative registries.
Results: A total of 474,022 unique respondents to the DNHS were included in this cohort, 8,460 of whom were diagnosed with VTE before the survey response date. The survey's response rate varied between 54% and 60%. The median age at the survey response date was 54 years (interquartile range: 40-66 years), and 46.1% of respondents were men. The cohort contains detailed information on lifestyle factors (smoking habits, alcohol consumption, physical activity level, and dietary habits), health status indicators (healthcare-seeking behavior, body mass index, self-rated health, and mental distress), and self-reported morbidities. In addition, the survey data were linked to records in Danish medical and administrative registries to obtain information on clinical data and outcomes, including hospitalizations, medication use, laboratory test results, labor market participation, vital status, and causes of death.
Discussion: The Danish Venous Thromboembolism Cohort is a valuable data resource for use in future studies on VTE research, with a focus on risk factors, complications, interactions, and prognosis.
期刊介绍:
Clinical Epidemiology is an international, peer reviewed, open access journal. Clinical Epidemiology focuses on the application of epidemiological principles and questions relating to patients and clinical care in terms of prevention, diagnosis, prognosis, and treatment.
Clinical Epidemiology welcomes papers covering these topics in form of original research and systematic reviews.
Clinical Epidemiology has a special interest in international electronic medical patient records and other routine health care data, especially as applied to safety of medical interventions, clinical utility of diagnostic procedures, understanding short- and long-term clinical course of diseases, clinical epidemiological and biostatistical methods, and systematic reviews.
When considering submission of a paper utilizing publicly-available data, authors should ensure that such studies add significantly to the body of knowledge and that they use appropriate validated methods for identifying health outcomes.
The journal has launched special series describing existing data sources for clinical epidemiology, international health care systems and validation studies of algorithms based on databases and registries.